Skip to main content

JANE STREET GROUP, LLC

Position in INO — Inovio Pharmaceuticals, Inc.

CIK 1595888 NEW YORK, NY

Position in INO

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$53,402
-$48,194 QoQ
Shares Held
30,691
-47.4% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in INO Over Time

Shares Held

Position Value (USD)

Derivatives in INO

reported options exposure · as of Mar 31, 2026
CallValue
$19,836
CallShares
11,400
PutValue
$70,992
PutShares
40,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,253,826,569 across 316 Biotechnology names. INO ranks #277 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in INO

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $70,992 40,800
2026-03-31 $53,402 30,691
2026-03-31 $19,836 11,400
2025-12-31 $30,276 17,400
2025-12-31 $101,596 58,389
2025-09-30 $75,127 32,106
2025-09-30 $92,898 39,700
2025-06-30 $80,952 39,683
2025-03-31 $20,137 12,354
2024-12-31 $72,658 39,704
2024-09-30 $105,149 18,192
2024-06-30 $178,010 22,031
2024-03-31 $442,146 31,855